Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. 144 Insider Sale of Securities
  2. 8-K Event Material agreement · Regulation FD disclosure
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 8-K Event Regulation FD disclosure · Other events
  6. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  7. 4 Planned sale Director sold 10,000 shares at an average $34.54 ($345,351)
  8. 144 Insider Sale of Securities
  9. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $39.79 ($198,971)
  10. 144 Insider Sale of Securities
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 144 Insider Sale of Securities
  20. ARS Other Annual Report to Security Holders

Page 3 of 40 · 798 filings